Linustatin is a naturally occurring cyanogenic glucoside found in various plants, including flaxseed. It is composed of a sugar moiety (glucose) linked to a cyanogenic aglycone (linamarin). The synthesis of linustatin involves the enzymatic condensation of linamarin with glucose. Research on linustatin has focused on its potential biological activities. Studies have shown that linustatin possesses antioxidant properties, which may contribute to its health benefits. It has been investigated for its anti-inflammatory, anticancer, and neuroprotective effects. The presence of linustatin in flaxseed has led to interest in its potential health implications, particularly its role in reducing the risk of cardiovascular disease and cancer. Further research is ongoing to elucidate the mechanisms of action of linustatin and its potential therapeutic applications.'
linustatin: cyanogenic glucoside from linseed oil; structure
ID Source | ID |
---|---|
PubMed CID | 119301 |
CHEBI ID | 6483 |
MeSH ID | M0079770 |
Synonym |
---|
propanenitrile, 2-((6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)-2-methyl- |
2-((6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)-2-methylpropanenitrile |
72229-40-4 |
linustatin |
C08333 |
2-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropanenitrile |
AC1Q4QUT , |
CHEBI:6483 |
[2-(6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyloxy)-2-methylpropiononitrile)] |
2-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-propanenitrile |
2-methyl-2-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)methyl)tetrahydro-2h-pyran-2-yloxy)propanenitrile |
2-[(6-o-hexopyranosylhexopyranosyl)oxy]-2-methylpropanenitrile |
DTXSID80992959 |
Q27107219 |
2-methyl-2-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)propanenitrile |
AKOS040752591 |
Linustatinase is an alpha beta dimer. Linamarase appears to be an alpha 5 beta 5 decamer.
Excerpt | Reference | Relevance |
---|---|---|
"Linustatinase is an alpha beta dimer (molecular weights of alpha and beta = 39,000 and 19,000, respectively) while linamarase appears to be an alpha 5 beta 5 decamer (molecular weights of alpha and beta = 62,500 and 65,000, respectively)." | ( Isolation and characterization of two cyanogenic beta-glucosidases from flax seeds. Conn, EE; Fan, TW, 1985) | 0.99 |
Class | Description |
---|---|
cyanogenic glycoside | A glycoside in which the aglycone contains a cyanide group. A cyanogenic glycoside can release poisonous hydrogen cyanide if acted upon by some enzyme. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Pathway | Proteins | Compounds |
---|---|---|
linustatin bioactivation | 0 | 10 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (26.59) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |